Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cytokines and Acute Phase Reactants as Markers of Pulmonary Tuberculosis Treatment

NCT00517231 is registered in ClinicalTrials.gov with UPECLIN HC FM Botucatu Unesp as lead sponsor.

NCT NCT00517231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00517231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cytokines and Acute Phase Reactants as Markers of Pulmonary Tuberculosis Treatment
Lead sponsor
UPECLIN HC FM Botucatu Unesp
Phase
Observational
Overall status
Withdrawn
Start date
June 30, 2005
Completion date
June 30, 2015
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary tuberculosis